Showing results (1-10 of 2) with videos related to
Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|July 15, 2025
ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapyPatrizia Murer, Laetitia Petersen, Nicole Egli, et al.RNA Biology|April 15, 2020
LARP1 isoform expression in human cancer cell linesHagen Schwenzer, Mai Abdel Mouti, Pia Neubert, et al.Pageof 1